Compared with opioids, other high impact drug classes like topicals, compound kits, combo packs, and specialty medications, represent proportionately low volume. However, they can be associated with exponentially significant costs. Recognizing the trends related to such cost drivers can help promote clinically-appropriate savings. Watch the video blog to learn more.
Q2 CASUALTY REPORT 2024
Utilization Review (UR) plays a crucial role in the workers' compensation system, ensuring that medical treatments provided to injured employees ar
New report reveals current trends for P&C industry SAN DIEGO, Calif.—Medical costs nationally have risen 11% in workers
Each quarter, Enlyte publishes its medical price index (MPI), which analyzes Enlyte’s medical bill review professional services charge data for tre
As reported by the Bureau of Labor and Statistics (BLS) for April 2024, the